Last reviewed · How we verify

NCT05098808

Artificial Intelligence in Diagnosing Dysphagia Patients

Completed Last updated 28 October 2021
What this trial tests

trial testing Acoustic features (from signals obtained during phonation) in Respiration Disorders in 449 participants. Completed in 1 October 2021.

Timeline
1 September 2019
Primary endpoint
1 September 2021
1 October 2021

Quick facts

Lead sponsorThe Catholic University of Korea
StatusCompleted
Study typeOBSERVATIONAL
Enrollment449
Start date1 September 2019
Primary completion1 September 2021
Estimated completion1 October 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

The Catholic University of Korea

Who can join

Adults 19 to 90, any sex, with Respiration Disorders or Swallowing Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective study we extracted acoustic parameters using PRAAT from patient's attempt to phonate during the clinical evaluation using a digital smart device. From these parameters we attempted (1) to define which of the PRAAT acoustic features best help to discriminate patients with dysphagia (2) to develop algorithms using sophisticated ML techniques that best classify those i) with dysphagia and those ii ) at high risk of respiratory complications due to poor cough force.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiration Disorders

Currently open trials in the same condition.

Other The Catholic University of Korea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05098808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing